Micro Cap Insider
Media & Technology
Emerging Markets
Street Watch
Small Caps
About MCD
Advertising
Analysts & Contributors
Contact Us
Privacy Policy
SEC Disclosure
Search
MICROCAP DAILY
MICROCAP DAILY
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Password recovery
Recover your password
your email
A password will be e-mailed to you.
Micro Cap Insider
Media & Technology
Emerging Markets
Street Watch
Small Caps
About MCD
Advertising
Analysts & Contributors
Contact Us
Privacy Policy
SEC Disclosure
Sign in / Join
15.8
C
Munich
MICROCAP DAILY
Saturday, July 24, 2021
Facebook
Twitter
Youtube
type here...
Search
Micro Cap Insider
Media & Technology
Emerging Markets
Street Watch
Small Caps
About MCD
Advertising
Analysts & Contributors
Contact Us
Privacy Policy
SEC Disclosure
MICROCAP DAILY
Micro Cap Insider
Media & Technology
Emerging Markets
Street Watch
Small Caps
About MCD
Advertising
Analysts & Contributors
Contact Us
Privacy Policy
SEC Disclosure
TAG
CytoDyn Inc.
BioPharma
CytoDyn’s Robust Platform Technology Keeps Expanding Into Breakthrough Therapy Designation Territory
Tom Rieder
-
July 19, 2021
Leronlimab is an immunomodulator that targets many diseases Multiple indications being pursued in parallel Proven safety profile, novel mechanism of action, & ease...
Latest news
PHI Group, Inc. (OTCMKTS: PHIL) Parabolic Move as M&A Player Nears Pink Current & Schedules Zoom Call for this Wednesday
July 24, 2021
Darkpulse Inc (OTCMKTS: DPLS) Move Brewing as Worldwide Leader in Distributed Fibre Sensor Solutions BOTDA Sees Growth Through Acquisition
July 24, 2021
Fernhill Corp (OTCMKTS: FERN) Major Runner as Emerging Crypto Player Signs LOI to Acquire SaaS Based Algorithmic Crypto Mining Operating System Platform
July 23, 2021
Cybernetic Technologies Ltd (OTCMKTS: HPIL) Powerful Reversal Brewing as Co Signs NDA with ANSYS to Develop the Apogee D7 and its Power Train Management...
July 23, 2021
PCT Ltd (OTCMKTS: PCTL) Powerful Reversal Forming as Hydrolyte Gains Traction and Investors Await Coming Release on Two New Subsidiaries & JVs
July 22, 2021
